Rob spent the last 10 years in the biotechnology industry leveraging microbes to tackle meaningful challenges. He cofounded Felix with colleagues from Yale and Berkeley to leverage a powerful new phage approach for managing bacterial infections.
Rob spent the last 10 years in the biotechnology industry leveraging microbes to tackle meaningful challenges. He cofounded Felix with colleagues from Yale and Berkeley to leverage a powerful new phage approach for managing bacterial infections.